Trial Profile
Non-Interventional Study to Evaluate Effect of Zoladex In EndometrioSIS.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Goserelin (Primary)
- Indications Endometriosis
- Focus Therapeutic Use
- Acronyms ESIS
- Sponsors AstraZeneca
- 11 Sep 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 30 Oct 2008 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 17 Oct 2008 New trial record.